Nektar Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.About NKTR
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.
NKTR Key Statistics
Stock Snapshot
With a market cap of 1.44B, Nektar Therapeutics(NKTR) trades at $69.97. The stock has a price-to-earnings ratio of -8.36.
On 2026-02-12, Nektar Therapeutics(NKTR) stock moved within a range of $60.54 to $72.31. With shares now at $69.97, the stock is trading +15.6% above its intraday low and -3.2% below the session's peak.
Trading volume for Nektar Therapeutics(NKTR) stock has reached 4.79M, versus its average volume of 1.78M.
Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $72.31 and a low of $6.48.
Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $72.31 and a low of $6.48.
NKTR News
Nektar Therapeutics ( ) shares have had a really impressive month, gaining 81% after a shaky period beforehand. This latest share price bounce rounds out a rema...
Nektar Therapeutics ( (NKTR) ) has shared an announcement. On February 10, 2025, Nektar Therapeutics reported positive 36-week blinded maintenance results from...
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.